Outcomes of surveillance VS. adjuvant chemotherapy for patients with STAGE IA and IB NON-seminomatous testicular germ-cell tumors.

Basit Öğe Kaydı
dc.authoridbayoglu, ibrahim vedat/0000-0002-0481-1084
dc.authoridBilici, Ahmet/0000-0002-3192-456X
dc.authoridCihan, Şener/0000-0002-3594-3661
dc.authoridCihan, Şener/0000-0002-3960-4982
dc.authoridOdabas, Hatice/0000-0002-5757-4705
dc.authorwosidSevinc, Alper/KFQ-6440-2024
dc.authorwosidturan, nedim/GXG-8035-2022
dc.authorwosidGumus, Mahmut/C-7135-2008
dc.authorwosidbayoglu, ibrahim vedat/HKN-8074-2023
dc.authorwosidGumus, Mahmut/HTO-4176-2023
dc.authorwosidBilici, Ahmet/E-2062-2018
dc.authorwosidCihan, Şener/AAW-1956-2021
dc.contributor.authorBilici, Ahmet
dc.contributor.authorGumus, Mahmut
dc.contributor.authorOdabas, Hatice
dc.contributor.authorKandemir, Nurten
dc.contributor.authorDemirci, Umut
dc.contributor.authorCihan, Sener
dc.contributor.authorBayoglu, Ibrahim Vedat
dc.date.accessioned2024-06-12T11:22:26Z
dc.date.available2024-06-12T11:22:26Z
dc.date.issued2016
dc.departmentTrakya Üniversitesien_US
dc.descriptionAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- JUN 03-07, 2016 -- Chicago, ILen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Soc Clin Oncolen_US
dc.identifier.doi10.1200/JCO.2016.34.15_suppl.e16051
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue15en_US
dc.identifier.urihttps://doi.org/10.1200/JCO.2016.34.15_suppl.e16051
dc.identifier.urihttps://hdl.handle.net/20.500.14551/25931
dc.identifier.volume34en_US
dc.identifier.wosWOS:000404711500029en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAmer Soc Clinical Oncologyen_US
dc.relation.ispartofJournal Of Clinical Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleOutcomes of surveillance VS. adjuvant chemotherapy for patients with STAGE IA and IB NON-seminomatous testicular germ-cell tumors.en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu